ITRAGEN 200MG CAPSULE contains Itraconazole 200mg, a broad-spectrum triazole antifungal agent effective against a variety of fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. It is indicated for the treatment of systemic and superficial mycoses, including blastomycosis, histoplasmosis, aspergillosis, onychomycosis, and other dermatophytic infections. ITRAGEN is administered orally and exhibits good bioavailability when taken with food. The drug undergoes hepatic metabolism primarily via the cytochrome P450 3A4 enzyme system, necessitating caution in patients with liver impairment and potential drug interactions. Common adverse effects include gastrointestinal disturbances, headache, and rash, while rare but serious effects may involve hepatotoxicity and cardiac issues such as congestive heart failure. Monitoring liver function tests during prolonged therapy is recommended. ITRAGEN should be used under medical supervision, with dosage adjustments based on the severity of infection and patient response. It is contraindicated in patients with known hypersensitivity to itraconazole or other azole antifungals and in those taking certain medications that may interact adversely. Proper adherence to prescribed treatment regimens is essential to ensure efficacy and minimize resistance development.